Apremilast Dimer | CAS 1802246-60-1 - Request Quote
Apremilast Dimer
| SZ CAT No: | SZ-A051021 |
| CAS No | 1802246-60-1 |
| Mol.F. | C30H27N3O9S |
| Mol.Wt. | 605.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apremilast Dimer is chemically (S)-N-(2'-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,1',3,3'-tetraoxo-[2,4'-biisoindolin]-4-yl)acetamide. Apremilast Dimer is supplied with detailed characterization data compliant with regulatory guideline. Apremilast Dimer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apremilast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1802246-60-1
Purchase 1802246-60-1
Order 1802246-60-1
Enquire 1802246-60-1
price of 1802246-60-1
1802246-60-1 Supplier
1802246-60-1 Manufacturer
1802246-60-1 Exporter
buy high quality Apremilast Dimer
Purchase Apremilast Dimer
Apremilast Dimer suppliers
Apremilast Dimer manufacturers
Apremilast Dimer price
Order Apremilast Dimer
Enquire Apremilast Dimer
Apremilast Dimer cost
Apremilast Dimer Supplier
Apremilast Dimer Distributor
Apremilast Dimer for Method Validation
Apremilast Reference Standard
Apremilast Dimer for ANDA Filing
Apremilast Dimer for Forced Degradation Studies
Apremilast Dimer Identification Standards
Apremilast Dimer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


